The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 2,000 shares, a decline of 78.7% from the June 30th total of 9,400 shares. Based on an average trading volume of 19,500 shares, the short-interest ratio is presently 0.1 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 1.1 %

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded up $0.21 during mid-day trading on Thursday, hitting $18.59. The stock had a trading volume of 3,433 shares, compared to its average volume of 21,300. The firm’s 50 day moving average is $18.23 and its 200 day moving average is $18.98. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a one year low of $15.60 and a one year high of $20.75.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Wednesday, May 1st were issued a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a dividend yield of 6.22%. The ex-dividend date was Tuesday, April 30th. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.